Brineura (cerliponase Alfa) Injection, 150 mg/5 Ml,

Brineura  (cerliponase alfa) is the only enzyme replacement therapy that helps treat CLN2 disease, a common form of Batten disease. Brineura is approved to slow loss of ability to walk or crawl (ambulation) in symptomatic pediatric patients 3 years of age and older with CLN2 disease.